RNTX CIK: 1420565

Rein Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.8
FY22:
−24.9
FY23:
−19.8
FY24:
−22.3
FY25:
−19.4
Change from FY21 to FY24
millions USD
FY21:
−35.9
FY22:
26.5
FY23:
16.2
FY24:
0
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
55.7
FY22:
–
FY23:
15.8
FY24:
17.8
FY25:
9.76
millions USD
FY21:
−4.01
FY22:
1.59
FY23:
12.1
FY24:
−4.47
FY25:
−9.65
(positive)
millions USD
FY21:
−23.9
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR